Arturo Molina, M.D., M.S., FACP
2018
In 2018, Arturo Molina, M.D., M.S., FACP earned a total compensation of $3.4M as Chief Medical Officer at SUTRO BIOPHARMA, a 486% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,150 |
|---|---|
| Option Awards | $2,306,240 |
| Salary | $440,300 |
| Stock Awards | $387,390 |
| Total | $3,354,080 |
FACP received $2.3M in option awards, accounting for 69% of the total pay in 2018.
FACP also received $220.2K in non-equity incentive plan, $440.3K in salary and $387.4K in stock awards.
Rankings
In 2018, Arturo Molina, M.D., M.S., FACP's compensation ranked 3,416th out of 14,244 executives tracked by ExecPay. In other words, FACP earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,416 out of 14,244 | 76th |
Division Manufacturing | 1,264 out of 5,762 | 78th |
Major group Chemicals And Allied Products | 443 out of 2,125 | 79th |
Industry group Drugs | 365 out of 1,814 | 80th |
Industry Biological Products, Except Diagnostic Substances | 79 out of 339 | 77th |
Source: SEC filing on April 25, 2019.
FACP's colleagues
We found two more compensation records of executives who worked with Arturo Molina, M.D., M.S., FACP at SUTRO BIOPHARMA in 2018.